ABSTRACT Antibodies are widely used for diagnostic and therapeutic applications because of their sensitive and specific recognition of a wide range of targets; however, their application is limited by their structural complexity. More demanding applications require greater stability than can be achieved by immunoglobulin-based reagents. Highly-stable, proteinbased affinity reagents are being investigated for this role with the goal of identifying a suitable scaffold that can attain specificity and sensitivity similar to that of antibodies while performing under conditions where antibodies fail. We have engineered Top7 a highly stable, computationally-designed protein to specifically bind human CD4 by inserting a peptide sequence derived from a CD4-specific antibody. Molecular dynamics simulations were used to evaluate the structural effect of the peptide insertion at a specific site within Top7 and suggest that this Top7 variant retains conformational stability over 100 °C. This engineered protein specifically binds CD4 and, consistent with simulations, is extremely resistant to thermal and chemical denaturation retaining its secondary structure up to at least 95°C and requiring 6 M guanidine to completely unfold. This CD4-specific protein demonstrates the functionality of Top7 as a viable scaffold for use as a general affinity reagent which could serve as a robust and inexpensive alternative to antibodies.
Revised: September 3, 2010 |
Published: March 25, 2009
Citation
Boschek C.B., D.O. Apiyo, T.A. Soares, H.E. Engelmann, N. Pefaur, T. Straatsma, and C.L. Baird. 2009.Engineering an ultra-stable affinity reagent based on Top7.Protein Engineering, Design & Selection 22, no. 5:325-332.PNNL-SA-63191.